GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
暂无分享，去创建一个
R. Ribeiro | F. Pimentel-Santos | A. Rodrigues | H. Canhão | I. McInnes | J. Fonseca | C. Catita | E. Vieira-Sousa | S. Pimenta | J. Borges | P. Pinto | G. Sequeira | J. Tavares-Costa | F. Teixeira | H. Santos | A. Bernardo | R. Aguiar | L. Teixeira | F. Martins | C. Ribeiro | T. Videira | J. Gomes | P. Alves | Pedro Ávila- Ribeiro